Chief Sales Officer, Tabula Rasa Healthcare
Kevin P. Boesen is the Chief Sales Officer of Tabula Rasa Healthcare (TRHC). Prior to joining TRHC, Dr. Boesen founded and served as CEO of the TRHC subsidiary, SinfoniaRx. Dr. Boesen also founded the University of Arizona Medication Management Center, SinfoniaRx’s predecessor, while serving as a faculty member at the University of Arizona College of Pharmacy. Dr. Boesen is a leader in the field of pharmacy and medication therapy management. He has served as the President of the Arizona Pharmacy Association and received numerous awards including the 2013 American Pharmacists Association Foundation Pinnacle Award, the 2009 and 2006 Arizona Pharmacy Association Innovative Practice Awards, 2009 Tucson's 40 under 40, and the 2011 National Community Pharmacists Association's Pharmacy Leadership Award. In addition to his positions at TRHC, SinfoniaRx and the University of Arizona College of Pharmacy, Dr. Boesen has worked in a variety of pharmacy and management positions. His experience included positions in hospital pharmacy, retail pharmacy, the pharmaceutical industry and the medical device industry. He also serves his community through a number of volunteer positions including the college of pharmacy’s National Advisory Board and the Catholic Foundation for the Diocese of Tucson board of directors.
CEO, The Pharmacy Group, LLC
Perry Cohen is a co-founder and Chief Executive Officer of The Pharmacy Group LLC. This company provides marketing services to healthcare, information technology and pharmaceutical companies Perry is a co-founder, past president and fellow of the Academy of Managed Care Pharmacy, a member of the Drug Topics Editorial Advisory Board, Managed Healthcare Executive Editorial Board of Advisors, and a member of the Dean’s Leadership Council, University of the Pacific School of Pharmacy. He holds a bachelor of science in pharmacy and doctor of pharmacy degrees from the University of the Pacific in Stockton, Calif.
Coit Financial Group
R. Ken Coit graduated from the University of Arizona with a bachelor's degree in pharmacy in 1967, but practiced pharmacy for just three years before beginning a career in investing and financial planning. Ken completed an MBA degree from Pepperdine University while developing his business. He is founder and head of Coit Financial and he is a private real estate investment banker who specializes in leveraged, multi-family properties located in California, Oregon, Washington, and Colorado. His investor portfolio is approaching $5 billion in value and the company manages more than 13,000 apartment units. He works with high net worth individuals and privately held foundations.
Jack R. Cole is dean emeritus and professor of pharmaceutical sciences at the University of Arizona College of Pharmacy. He received his bachelor of science in pharmacy degree from the University of Arizona in 1953 and his doctor of philosophy in medicinal chemistry from the University of Minnesota in 1957. Jack was the dean of the College of Pharmacy from 1977 to 1990, and later became the provost and senior vice president for academic affairs for the university. Jack also served as the director of graduate education, research and scholarship at the American Association of Colleges of Pharmacy from 1992 to 1994.
Retired, West Region Director, Pharmacy Practice for Cardinal Health Innovative Delivery Solutions
Anne Freyer has a 40-year career in hospital pharmacy management and administration. Her strengths include pharmacy operations and 12 years of experience in home care and infusion therapy. Anne has a strong record of managing and directing pharmacy operations and clinical projects for leading health-care companies. Anne received her master’s from the University of Arizona and MBA from the University of Phoenix. She joined Cardinal Health in 1997 and retired as West Region Director of Pharmacy Practice (RDPP) for Cardinal Health Innovative Delivery Solutions. In 2013, Anne was named RDPP of the year. Anne is a fellow at American Academy of Healthcare Executives (ACHE). Anne has held office in a number of state and national level societies and currently is a member of the advisory board for the University of Arizona College of Pharmacy. Anne has published and presented topics related to home infusion, benchmarking, and productivity.
Chief Executive Officer, Banner Pharmacy Services
Russ Funk was appointed CEO of Banner Pharmacy Services in July 2018 following a broad range of leadership experiences within the healthcare market to include activities throughout the continuum of care focused on innovative strategies and developing new products/solutions that enhance quality of life for both the patients and caregivers. A Healthcare Leader and Strategist who can lead sales, operations and business development activities. Accomplished at increasing revenue growth, operational efficiency and market share. Highly skilled at identifying opportunities, developing and implementing innovative strategies and developing new products. Proven ability in developing strategic relationships within complex organizations. Funk has spent the last eight years working as a Strategic Customer Vice President for Becton Dickinson. Prior to that, he held many healthcare roles in clinical and operational pharmacy leadership, product management, and leading sales and marketing teams. Funk completed his Pharm D from Creighton University and a Master's of Healthcare Services Administration from the University of Kansas. Funk, a native of Kansas, moved to Arizona in 2018. He holds a Doctor of Pharmacy degree from Creighton University and a Masters of Health Services Administration degree from the University of Kansas. He is currently a member of ACHE and Serves on the Excelera Board.
President, Bravo Pharmacy
Stan Goldenberg is the president of the LTC Division, Downey Plaza Pharmacy, he is a senior associate of Strom and Associates, LLC, and is the founder of Bravo Pharmacy, a retail pharmacy begun in 2008 to serve the underserved community of Los Angeles. He is a pharmacy consultant and entrepreneur with over 40 years of leadership experience in the pharmaceutical industry, specializing in long-term care (LTC) and senior-care pharmacy. A 1968 graduate of the UA College of Pharmacy, he has developed pharmacy, home health infusion, nursing home and other healthcare enterprises in Los Angeles. He was a member of the California State Board of Pharmacy from 2001 to 2009 and served two consecutive terms as president. He is a charter member of the college’s National Advisory Board and served as its chair from 2001 to 2009.
Co-Founder, Modern Health Inc.
Ira Halpern co-founded ModernHEALTHcare Inc. in 1975 and co-founded modern HOMEcare, Inc, in 1989. In his role as president of Modern HEALTH, he is primarily responsible for strategic business development, sales, and marketing. He holds a BS in pharmacy from UA and a BA in business administration from California State University in Northridge.
Vice President, Blue Cross Blue Shield of Arizona
Chris Hogan is the vice president of pharmacy management at Blue Cross Blue Shield of Arizona. He is responsible for formulating clinical pharmacy policy, establishing and maintaining the national pharmacy network and managing relationships with pharmaceutical manufacturers and claims processing vendors. Chris was the vice president of sales for United Drugs and a department director at Phoenix Memorial Hospital. He is a member of the Academy of Managed Care Pharmacy and the Arizona Pharmacy Association, who presented him with the Bowl of Hygeia Award for community service in 2004. Chris received a bachelor’s degree in pharmacy from the University of Arizona, a master’s in business administration from the University of Phoenix and a graduate certificate in nonprofit leadership and management from Arizona State University.
Foundation Medicine, Roche Group
Vice President, Commercial Programs
Kathleen Kaa is the Vice President of Commercial Programs at Foundation Medicine, enabling deep partnerships with organized oncology customers across the U.S. Prior to this role she was Head of Global Pricing and Market Access for Roche Oncology, developing and driving global strategies to optimize market access for early and late-stage products. At Genentech, Kathleen held senior leadership positions in reimbursement operations and field reimbursement; managed care marketing; and in value-based healthcare where she supported providers, patients, brand teams, and led engagements with U.S. commercial payers.
Prior to joining Roche, Kathleen led AmerisourceBergen Specialty Group data and informatics teams; private payer consulting practices at Lash Group; and was the President of Managed Care Network. She has significant national clinical and health plan management experience from her tenure at Aetna and Prudential Healthcare in areas of clinical and formulary management, pharmacoeconomics, program and business development, and disease management. She has served on the Board of Directors for the Academy of Managed Care Pharmacy and Trustees for the AMCP Foundation.
Kathleen holds a Ph.D. Pharmacy Administration, Economics from the University of South Carolina and a B.S. Pharmacy from the University of Washington.
CEO, Modern Health Inc.
Richard Katz has been the chief executive officer of ModernHEALTH companies since he began the company in 1975. ModernHEALTH sells specialty pharmacy products and services to healthcare providers and users. Currently, the company specializes in prescription services for disease-payment and service-specific needs. Richard completed a master’s in public administration from the University of Southern California in 1973. He also has a bachelor of science in pharmacy from the University of Arizona. He is a member of the National Community Pharmacists Association and the American Pharmaceutical Association. He became president of the College of Pharmacy National Advisory Board in 2009.
President/CEO, Research Corporation Technologies
Shaun Kirkpatrick is the president and chief executive officer of Research Corporation Technologies (RCT), based in Tucson. Shaun oversees RCT’s BioVentures investment portfolio and technology department, and the licensing of activities in North America, Europe, and Australia. Shaun received his master’s degree in international economics and science/technology in international economics from Johns Hopkins University School of Advanced International Studies. He attended UA as a Flinn Foundation Scholar and graduated with a double major in economics and biology. He is a board member for the Flinn Foundation and the Critical Path Institute, and also serves on the boards of several companies in RCT’s BioVentures investment portfolio.
President, Djinnistan Holdings, LLC
John Musil is the founder of Avella Specialty Pharmacy, which was acquired by UnitedHealthCare in 2018. Avella is a national specialty pharmacy focused on clinical management of patients with rare diseases. John is a 1994 graduate of the UA College of Pharmacy and a recipient of the 2010 Young Professional Achievement Award given by the Arizona Alumni Association. In 2012, Avella received the Arizona Corporate Excellence Award as the fastest-growing privately held company based in Arizona and was a twelve-time recipient as one of the 5,000 fastest-growing companies in America by Inc. magazine.
General Counsel, Arrowhead Pharmaceuticals
Patrick O'Brien is the general counsel for Arrowhead Pharmaceuticals in Pasadena, California. Before that he was the group vice president and chief legal officer of Shire Pharmaceuticals, a global company headquartered in Ireland. Patrick received both a BS Pharmacy and a PharmD from UA and completed a residency at the University of Michigan. In 1993, he earned a JD degree from UA. Before joining Shire in 2012, O'Brien was a partner in several law firms and, among other positions, counsel for Johnson & Johnson, ALZA Corporation and the U.S. Food and Drug Administration. Patrick joined the NAB in 2014.
Acting Professor & Vice Chair of Education in Anesthesiology, School of Medicine/Emory University
Chief, Division of Surgical Specialties Anesthesiology, Emory University Hospital Midtown
Cathleen Peterson-Layne is a professor of anesthesiology and Director of Obstetric Anesthesiology at the University of Nebraska Medical Center/Nebraska Medicine in Omaha, NE. After receiving her BS from UA College of Pharmacy in 1988, Cathleen earned her PhD in pharmacology, then her MD at Duke University. Following a residency in anesthesiology at Duke University, she served on the School of Medicine faculty at the University of North Carolina, then Duke University. In 2016, Cathleen was recruited to Nebraska to develop and lead a division of obstetric anesthesiology. Her profession passions are safe maternal care and resident education. Cathleen serves the American Board of Anesthesiology as an oral board examiner and exam writer. She is also involved in developing a new assessment for board certification using OSCEs.
President and CEO, C-Path Institute
Joseph Scheeren, PharmD, worked in R&D in the Pharmaceutical Industry for over 35 years in the USA, China and Europe. He led Regulatory Affairs and Development in US/China in Bayer in the last 15 years. Since January 2019, he is Adjunct Professor at Peking University for Regulatory Sciences in the Department of Clinical Research. In April 2019 he joined C-Path Institute as its President and CEO. Dr. Scheeren serves on Advisory Boards at the Center for Innovation in Regulatory Science, the Regulatory Affairs Track at Yale University, the Center of Regulatory Excellence in Singapore. He is also a foreign member of the Academie Nationale de Pharmacie in France, and a lecturer at Yale University. Dr. Scheeren studied pharmacy at the University of Leiden.
National Advisory Board Member
Howard J. Schaeffer Endowed Chair in Pharmaceutical Sciences
Rick G. Schnellmann, PhD, is dean of the University of Arizona College of Pharmacy. A leading pharmacologist, researcher and drug discovery entrepreneur, he joined the UA in August 2016. Dr. Schnellmann earned his doctorate in pharmacology and toxicology from the University of Arizona College of Pharmacy and Medicine in 1984. Previously, Dr. Schnellmann worked at the South Carolina College of Pharmacy at the Medical University of South Carolina (MUSC) in Charleston, where he was an eminent scholar and distinguished university professor and was chair of the college's Department of Drug Discovery and Biomedical Sciences from 2001 to 2015. Under his guidance, his department's NIH grant funding increased, and in 2014 the school was ranked 11th in NIH funding among colleges of pharmacy. Dr. Schnellmann's research is focused on identifying and developing drugs to treat acute kidney injury, diabetic kidney disease, stroke, spinal cord injury and Parkinson's disease. His research has been funded continuously since 1987 and includes NIH grant funding totaling more than $30 million. He has been instrumental in founding three MUSC spin-off biotechnology companies focused on drug discovery and development.
Chairman, High Throughput Genomics
Co-Founder/CSO, BioSpyder Technologies Inc.
Bruce Seligmann is the co-founder and CSO of BioSpyder Technologies, Inc., and is conducting research in collaboration with the University of Arizona Cancer Center. He's also the co-founder, director, chief science officer and vice president of research at High Throughput Genomics based in Tucson. Through his work, Bruce has provided time-and cost-saving technology that assists the advancement of research, drug discovery and the development of better therapies and diagnostics. Bruce is also the founder of Systems Integration Drug Discovery Co., which was sold to Discovery Partners International. Before that, he was the vice president of research and development and the center director at the biotech company Selectide.
Aclairo, Senior Consultant and Founder
Hilary Sheevers received her PhD from the University of Arizona in 1994, under Dr. A. Jay Gandolfi. After leaving Arizona, Dr. Sheevers was employed in CDER at FDA, Washington, D.C., as a reviewer and a supervisor. At FDA, she served on or chaired committees including carcinogenicity, reproductive and developmental toxicity, phototoxicity, botanical products, and excipients. Since leaving FDA, Hilary has consulted as a senior toxicologist to the pharmaceutical industry, and founded Aclairo PDG, Inc., a consulting firm that specializes in drugs and biologics development. Hilary recent experiences include development programs across indications, including programs in oncology, pulmonary, anti-viral/bacteria, neurology, psychiatry, GI, inflammatory diseases, and pain. Hilary’s clients include large and mid-size pharma, as well as biotechs. Aclairo was sold to Experimental Pathology Laboratories (EPL, Inc.) in 2016. At Aclairo, Hilary served as president for 13 years, and now serves as senior consultant and founder to aid in succession planning.
Dr. I. Glenn Sipes is Professor Emeritus at the University of Arizona. While at Arizona, his research program focused on the biotransformation of xenobiotics and on chemical-induced liver and ovarian injury. He authored over 250 research publications and was a co-editor-in-chief of Comprehensive Toxicology (13 volumes). For 29 years he served as head of the Departments of Pharmacology and Toxicology at the UA College of Pharmacy and of Pharmacology in the UA College of Medicine. He was also the founding director of both the Center for Toxicology and the Southwest Environmental Health Sciences Center.
Dr. Sipes participated in a number of professional/scientific organizations. He served as president of the Society of Toxicology and was editor of its journal, Toxicology and Applied Pharmacology. He also served as president of the International Union of Toxicology. He was a member of the National Academy of Sciences Committee of Toxicology, as well as its Board of Environmental Health Sciences Council (NIEHS). Dr. Sipes was elected a Fellow of AAAS and of the Academy of Toxicology Sciences for which he served as president. For 20 years he has been a technical adviser to the WHO's JECFA and a member and chair of the Research Institute for Fragrance Material's Expert Panel. Recent honors include the 2011 Distinguished Scientist Award from the American College of Toxicology, 2015 Mildred S. Christian Career Achievement Award from The Academy of Toxicological Sciences and the 2016 Society of Toxicology Distinguished Toxicology Scholar Award.
Executive Director of Drug Metabolism and Pharmacokinetics, Gilead
Bill is currently an Executive Director at Gilead Sciences in Foster City, CA and head of the Drug Metabolism and Pharmacokinetics department. The DMPK department provides nonclinical in vitro and in vivo data to support drug discovery and development. Bill received a B.S. in Pharmacy from the University of Utah, a Ph.D. in Pharm/Tox from the University of Arizona and completed post-doctoral training at the National Institute of Environmental Health Sciences. Bill then joined the pharmaceutical industry where he has spent the past 29 years in a variety of DMPK roles to support drug research and development phases and contributed to several marketed products. He is the co-author of 40 research articles, past Editorial Board Member and Associate Editor of Drug Metabolism and Disposition and past president of the International Society for the Study of Xenobiotics (ISSX).
Chief Operating Officer and Executive Vice President, ScriptSave
Marcus Sredzinski is the chief operating officer and executive vice president of Medical Security Card Company, LLC and ScriptSave in Tucson, where he is responsible for pharmacy strategic initiatives including clinical programs, operations and trade relations. Prior to joining ScriptSave, Marcus was a managed care executive of national accounts for Elan Pharmaceuticals and pharmacy director at HealthPartners Health Plan. A 1991 graduate of the UA College of Pharmacy, he holds a bachelor of science degree in microbiology and chemistry and a doctor of pharmacy degree. He is a member of the Academy of Managed Care Pharmacy and the Arizona Society for Hospital Pharmacy. He's served on the NAB since 2004.
President & CEO, NCPDP
Lee Ann Stember is President & CEO of NCPDP, a not-for-profit multi-stakeholder forum for developing healthcare business solutions, including ANSI-accredited standards for electronic exchange of healthcare information. As President & CEO for nearly four decades, she has led NCPDP to continued success in its transformative role in pharmacy services, creating and promoting adoption of consensus-based standards and best practices that improve patient safety and decrease costs.
Stember represents the Council and work of its membership to government agencies, other standards development organizations, healthcare industry associations and coalitions seeking to achieve HIT interoperability and other reforms that improve the coordination and quality of care while reducing system costs. She currently serves on the board of the Workgroup for Electronic Data Interchange (WEDI), the CAQH/CORE Advisory Board, and the boards of the MedData Foundation and the NCPDP Foundation. She is a member of the American Management Association (AMA) and the American Society of Association Executives (ASAE) as well as numerous healthcare organizations, including the Academy of Managed Care Pharmacy (AMCP), National Association of Chain Drug Stores (NACDS), National Community Pharmacists Association (NCPA), American Pharmaceutical Association (APhA),American Society of Health-System Pharmacists (ASHP), American Society of Consultant Pharmacists (ASCP), and Healthcare Information and Management Systems Society (HIMSS).
Stember has a Bachelor of Science degree from the University of Arizona College of Business.
Greg Watanabe joined MedImpact Healthcare Systems in 2005 and served in senior positions in operations, sales, innovation and strategy before being appointed president in 2010. Previously he owned and operated a community pharmacy in Tucson and then spent 20 years in various positions of increasing responsibility in managed health care and pharmacy benefit industries. He graduated with a bachelor of science in pharmacy and a master's in business administration from the University of Arizona.
Retired, Director, Eli Lilly and Company
William Wheeler was the director of national accounts at Eli Lilly and Company from 1982 to 1997. He worked at Eli Lilly his entire professional life, beginning as an associate in 1965. William holds a bachelor’s degree in pharmacy from the University of Arizona and a master’s of business administration from Arizona State University. He has served on the Advisory Board for the National Employers Group. William was an officer in the U.S. Air Force Medical Service Corps from 1962 to 1965.